Search research articles
Contact Us
Filters
Showing results (411-420 of 470) with videos related to
Page
of 47
Sort By:
Ophthalmology Science
|
October 17, 2022
YOSEMITE and RHINE: Phase 3 Randomized Clinical Trials of Faricimab for Diabetic Macular Edema: Study Design and Rationale
Nicole Eter, Rishi P Singh, Francis Abreu, et al.
Viruses
|
September 28, 2023
Adipose Tissues from Human and Bat-Derived Cell Lines Support Ebola Virus Infection
Lauren Garnett, Kaylie N Tran, Zachary Schiffman, et al.
Plos One
|
January 27, 2026
Ultraviolet light and polyethylene glycol as environmental cleaning agents to reduce contamination of Pseudogymnoascus destructans in bat hibernacula
Alyssa J Stulberg, Tina L Cheng, Katy L Parise, et al.
Ophthalmic Epidemiology
|
February 6, 2024
Progress Towards Elimination of Trachoma in Kenya 2017-2020
D Ilako, S Mwatha, Barasa E Wanyama, et al.
Journal of Oral Microbiology
|
January 18, 2021
Oral microbiome in down syndrome and its implications on oral health
Jesse R Willis, Susana Iraola-Guzmán, Ester Saus, et al.
NPJ Biofilms and Microbiomes
|
May 18, 2022
Citizen-science reveals changes in the oral microbiome in Spain through age and lifestyle factors
Jesse R Willis, Ester Saus, Susana Iraola-Guzmán, et al.
Ophthalmology Science
|
October 9, 2023
BALATON and COMINO: Phase III Randomized Clinical Trials of Faricimab for Retinal Vein Occlusion: Study Design and Rationale
Lars-Olof Hattenbach, Francis Abreu, Pablo Arrisi, et al.
The Journal of Antimicrobial Chemotherapy
|
May 5, 2012
Safety and pharmacokinetics of aciclovir in women following release from a silicone elastomer vaginal ring
M J Keller, A M Malone, C A Carpenter, et al.
Ophthalmology
|
March 4, 2023
Archway Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration 2-Year Results
Carl Regillo, Brian Berger, Logan Brooks, et al.
Ophthalmology. Retina
|
March 19, 2025
Faricimab Treat-and-Extend Dosing for Macular Edema Due to Retinal Vein Occlusion: 72-Week Results from the BALATON and COMINO Trials
Carl J Danzig, Christiana Dinah, Faruque Ghanchi, et al.
Page
of 47
Search research articles
Search
Showing results (411-420 of 470) with videos related to
Sort By:
Page
of 47
Ophthalmology Science
|
October 17, 2022
YOSEMITE and RHINE: Phase 3 Randomized Clinical Trials of Faricimab for Diabetic Macular Edema: Study Design and Rationale
Nicole Eter, Rishi P Singh, Francis Abreu, et al.
Viruses
|
September 28, 2023
Adipose Tissues from Human and Bat-Derived Cell Lines Support Ebola Virus Infection
Lauren Garnett, Kaylie N Tran, Zachary Schiffman, et al.
Plos One
|
January 27, 2026
Ultraviolet light and polyethylene glycol as environmental cleaning agents to reduce contamination of Pseudogymnoascus destructans in bat hibernacula
Alyssa J Stulberg, Tina L Cheng, Katy L Parise, et al.
Ophthalmic Epidemiology
|
February 6, 2024
Progress Towards Elimination of Trachoma in Kenya 2017-2020
D Ilako, S Mwatha, Barasa E Wanyama, et al.
Journal of Oral Microbiology
|
January 18, 2021
Oral microbiome in down syndrome and its implications on oral health
Jesse R Willis, Susana Iraola-Guzmán, Ester Saus, et al.
NPJ Biofilms and Microbiomes
|
May 18, 2022
Citizen-science reveals changes in the oral microbiome in Spain through age and lifestyle factors
Jesse R Willis, Ester Saus, Susana Iraola-Guzmán, et al.
Ophthalmology Science
|
October 9, 2023
BALATON and COMINO: Phase III Randomized Clinical Trials of Faricimab for Retinal Vein Occlusion: Study Design and Rationale
Lars-Olof Hattenbach, Francis Abreu, Pablo Arrisi, et al.
The Journal of Antimicrobial Chemotherapy
|
May 5, 2012
Safety and pharmacokinetics of aciclovir in women following release from a silicone elastomer vaginal ring
M J Keller, A M Malone, C A Carpenter, et al.
Ophthalmology
|
March 4, 2023
Archway Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration 2-Year Results
Carl Regillo, Brian Berger, Logan Brooks, et al.
Ophthalmology. Retina
|
March 19, 2025
Faricimab Treat-and-Extend Dosing for Macular Edema Due to Retinal Vein Occlusion: 72-Week Results from the BALATON and COMINO Trials
Carl J Danzig, Christiana Dinah, Faruque Ghanchi, et al.
Page
of 47